HealthyDirect · GrowthFit for a long SIP
Invesco India Focused Fund
Invesco Mutual FundEquity Schemes - Focused Fund6.1 years
The scheme seeks to generate capital appreciation by investing in upto 20 stocks across market capitalization.
- NAV
- 31.60
- 30 Oct 2026
- 1Y
- +3.0%
- Trailing CAGR
- AUM
- ₹6,228.51 Cr
- 30 Sept 2026
- Volatility
- Medium
- 15.2% annualized
Buying brief
Should you add this fund?
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 29 Oct 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · The fund beat the category median in 96% of rolling 3-year windows.
Fits if · Three-year return is above the category median.
Buy checklist
History depth
Pass
6.1 years of path to read.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
Pass
0.69% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -22.0%. Ask whether you can hold through a similar fall.
Vs category
Pass
96% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
Pass
Hiten Jain · 4.1 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 53.1% of the portfolio.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
Before you buy or SIP
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 22%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
If you start a SIP here, diary a 90-day check and an annual review - don’t react to every NAV print.
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y+3.0%
- 3Y+21.2%
- 5Y+14.3%
- 10Yn/a
- SI+20.8%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y+15.2%
- 3Y+9.8%
- 5Y+16.3%
- 10Yn/a
- Since inception
- +20.8%
- Calendar-day CAGR
- Excess 1Y
- +10.4%
- Category median, same plan and option
- 3Y win rate
- +96%
- Windows beating the median
- 3Y percentile
- 100
- Vs comparable share classes
- SIP 3Y XIRR
- +9.8%
- Simulated monthly SIP
- Worst rolling 3Y
- +17.7%
- 758 daily-ending windows
- Median rolling 3Y
- +23.1%
- Calendar-day CAGR
- Positive rolling 5Y
- +100%
- 265 daily-ending windows
Drawdown
Peak to trough from a running NAV high, with the path and recovery episodes.
- Max drawdown
- -22.0%
- Worst peak-to-trough
- Current
- -4.6%
- Below last peak
- Current spell
- 62 days
- Days below latest peak
- Time below peak
- +83%
- NAV observations
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 12 days
- 77 recovered episodes
- Longest recovery
- 425 days
- Trough to prior peak
14 Jan 2022 – 16 Aug 2023
Trough 17 Jun 2022 · recovered in 425 days
-22.0%
16 Dec 2024 – 29 Jul 2026
Trough 23 Mar 2026 · recovered in 128 days
-21.7%
28 Aug 2026 – open
Trough 23 Oct 2026 · not recovered
-9.0%
24 Sept 2024 – 9 Dec 2024
Trough 13 Nov 2024 · recovered in 26 days
-8.4%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
100
Vs category
100
Consistency
76
Risk-adjusted
73
Drawdown
45
Mean
79
Decision
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Healthy
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
- No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Supporting reads
- The fund beat the category median in 96% of rolling 3-year windows.
- Three-year return is above the category median.
- Risk-adjusted return sits above the documented risk-free proxy.
Portfolio
30 Sept 2026 · 28 holdings · top 10 are 53.1%.
- Top 5
- 31.5%
- Top 10
- 53.1%
- Largest holding
- 8.6%
- Effective holdings
- 22.7
ICICI Bank Ltd
Financial
8.6%
Larsen & Toubro Ltd
Industrials
6.3%
Interglobe Aviation Ltd
Industrials
5.8%
HDFC Bank Ltd
Financial
5.6%
Coforge Ltd
Technology
5.2%
Worth investigating
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Mahindra Manulife Focused Fund
Mahindra Manulife Mutual Fund
- 1Y
- -8.3%
- 3Y
- +12.7%
- Vol
- 14.2%
- Max DD
- -16.5%
- Sharpe
- 0.88
- 3Y win
- +100%
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
Caveat: Higher TER · Lower trailing returns
Canara Robeco Focused Fund
Canara Robeco Mutual Fund
- 1Y
- -8.3%
- 3Y
- +12.8%
- Vol
- 13.4%
- Max DD
- -18.1%
- Sharpe
- 0.61
- 3Y win
- +71%
- Lower volatility
- Shallower drawdown
Caveat: Higher TER · Lower trailing returns
UTI Focused Fund (30 stocks)
UTI Mutual Fund
- 1Y
- -6.6%
- 3Y
- +10.0%
- Vol
- 13.5%
- Max DD
- -19.3%
- Sharpe
- 0.31
- 3Y win
- 0%
- Lower volatility
- Shallower drawdown
Caveat: Higher TER · Lower trailing returns
HSBC Focused Fund
HSBC Mutual Fund
- 1Y
- +1.2%
- 3Y
- +13.8%
- Vol
- 15.7%
- Max DD
- -21.2%
- Sharpe
- 0.77
- 3Y win
- +29%
- Shallower drawdown
Caveat: Higher volatility · Higher TER · Lower trailing returns
ICICI Prudential Focused Fund
ICICI Prudential Mutual Fund
- 1Y
- -4.8%
- 3Y
- +16.9%
- Vol
- 15.1%
- Max DD
- -34.1%
- Sharpe
- 0.63
- 3Y win
- +47%
- Lower volatility
Caveat: Deeper drawdown · Higher TER · Lower trailing returns